First FDA-Approved Study of Stem Cells to Treat Hearing Loss
Children’s Memorial Hermann Hospital and Cord Blood Registry (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss.
Read More